% This is the RIPE Database query service.
% The objects are in RPSL format.
%
% The RIPE Database is subject to Terms and Conditions.
% See http://www.ripe.net/db/support/db-terms-conditions.pdf
% Information related to '193.242.218.0 - 193.242.219.255'
% Abuse contact for '193.242.218.0 - 193.242.219.255' is '[email protected]'
inetnum: 193.242.218.0 - 193.242.219.255
netname: DC-FERRING
country: DE
org: ORG-FI18-RIPE
admin-c: LAHA3-RIPE
tech-c: LAHA3-RIPE
status: ASSIGNED PI
mnt-by: RIPE-NCC-END-MNT
mnt-by: HRW-NOC
mnt-by: FERRING
mnt-routes: HRW-NOC
mnt-domains: HRW-NOC
notify: [email protected]
created: 2012-06-27T13:12:36Z
last-modified: 2019-01-24T08:45:19Z
source: RIPE
sponsoring-org: ORG-IG20-RIPE
organisation: ORG-FI18-RIPE
org-name: FERRING INTERNATIONAL CENTER S.A.
country: CH
org-type: OTHER
address: 1162 Saint-Prex
address: Switzerland
e-mail: [email protected]
abuse-c: FAM57-RIPE
mnt-ref: HRW-NOC
mnt-by: HRW-NOC
created: 2012-06-22T11:24:35Z
last-modified: 2022-12-01T16:25:49Z
source: RIPE
person: Lars Merling
address: Ferring Pharmaceuticals A/S
address: Amager Strandvej 405
address: 2770 Kastrup
address: Denmark
phone: +45 28787142
fax-no: +45 28176142
e-mail: [email protected]
e-mail: [email protected]
nic-hdl: LAHA3-RIPE
mnt-by: RESILANS-MNT
mnt-by: FERRING
mnt-by: MERLING
created: 1970-01-01T00:00:00Z
last-modified: 2022-07-14T11:42:14Z
source: RIPE